Mai Capital Management Moderna, Inc. Call Options Transaction History

Mai Capital Management

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Jul 19, 2022	SELL	$117.13 - $176.59 $58,565 - $88,295	-500 Reduced 62.5%	300 $43,000
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $135,492 - $221,106	-600 Reduced 42.86%	800 $203,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $244,090 - $532,917	1,100 Added 366.67%	1,400 $538,000
Q2 2021 Jul 19, 2021	BUY	$129.91 - $234.98 $38,973 - $70,494	300 New	300 $70,000
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $98,609 - $254,790	-1,500 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$54.34 - $94.85 $81,510 - $142,275	1,500 New	1,500 $106,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

Stay updated on Mai Capital Management with notifications on news.